A detailed history of Trust CO Of Vermont transactions in Astrazeneca PLC stock. As of the latest transaction made, Trust CO Of Vermont holds 630 shares of AZN stock, worth $40,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares
630
Previous 2,271 72.26%
Holding current value
$40,483
Previous $177,000 72.32%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$76.67 - $87.62 $125,815 - $143,784
-1,641 Reduced 72.26%
630 $49,000
Q2 2024

Jul 09, 2024

SELL
$66.81 - $80.83 $54,851 - $66,361
-821 Reduced 26.55%
2,271 $177,000
Q1 2024

May 03, 2024

BUY
$61.03 - $69.57 $108,694 - $123,904
1,781 Added 135.85%
3,092 $209,000
Q4 2023

Mar 08, 2024

SELL
$61.89 - $69.28 $231,654 - $259,315
-3,743 Reduced 74.06%
1,311 $88,000
Q3 2023

Nov 27, 2023

SELL
$64.85 - $71.7 $26,912 - $29,755
-415 Reduced 7.59%
5,054 $342,000
Q1 2023

Apr 07, 2023

BUY
$63.15 - $71.6 $10,419 - $11,813
165 Added 3.11%
5,469 $379,000
Q4 2022

Feb 09, 2023

BUY
$54.21 - $70.44 $4,607 - $5,987
85 Added 1.63%
5,304 $359,000
Q3 2022

Oct 24, 2022

BUY
$53.02 - $135.75 $6,362 - $16,290
120 Added 2.35%
5,219 $287,000
Q2 2022

Jul 20, 2022

BUY
$59.26 - $71.14 $2,903 - $3,485
49 Added 0.97%
5,099 $337,000
Q3 2021

Oct 22, 2021

BUY
$55.56 - $60.79 $61,116 - $66,869
1,100 Added 27.85%
5,050 $303,000
Q2 2021

Jul 15, 2021

SELL
$48.42 - $60.18 $14,477 - $17,993
-299 Reduced 7.04%
3,950 $237,000
Q4 2020

Feb 03, 2021

SELL
$48.52 - $58.02 $16,690 - $19,958
-344 Reduced 7.49%
4,249 $212,000
Q3 2020

Nov 06, 2020

BUY
$53.07 - $61.1 $30,515 - $35,132
575 Added 14.31%
4,593 $252,000
Q2 2020

Jul 17, 2020

BUY
$43.1 - $55.31 $8,620 - $11,062
200 Added 5.24%
4,018 $212,000
Q1 2020

Apr 24, 2020

BUY
$37.79 - $51.33 $22,674 - $30,798
600 Added 18.65%
3,818 $171,000
Q3 2019

Oct 24, 2019

SELL
$40.12 - $45.47 $14,844 - $16,823
-370 Reduced 10.31%
3,218 $143,000
Q2 2019

Jul 26, 2019

BUY
$37.28 - $41.68 $3,317 - $3,709
89 Added 2.54%
3,588 $148,000
Q1 2019

May 01, 2019

BUY
$35.49 - $43.02 $7,452 - $9,034
210 Added 6.38%
3,499 $141,000
Q3 2018

Oct 26, 2018

BUY
$34.76 - $39.72 $26,070 - $29,790
750 Added 29.54%
3,289 $130,000
Q2 2018

Jul 11, 2018

BUY
$34.55 - $37.05 $5,838 - $6,261
169 Added 7.13%
2,539 $89,000
Q3 2017

Oct 24, 2017

BUY
$28.96 - $34.0 $68,635 - $80,580
2,370
2,370 $81,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.